O'CONNELL JOSEPH P (Chief Medical Officer) received a stock award from ODONATE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/3/2020ACC: 0001209191-20-056585
Officer· Chief Medical Officer
Since Jun 2018
+254.00
Net shares
Net buyer
$1.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
254.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+127.00
Price / share
$12.25
Trade value
$1.56K
% of position
5.1%
10/30/2020
2.50K→2.63K
Total
Net shares
+127.00
Net value
$1.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/30/2020 | A · Award | +127.00 | $12.25 | $1.56K | 5.1% | 2.50K | 2.63K |
| Total | +127.00 | $1.56K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
127.00 shares
Shares
+127.00
Strike price
14.41
Held after
127.00
Exercisable
—
10/30/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock127.00 shares | 10/30/2020 | A · Award | +127.00 | 14.41 | — | 127.00 |